Marijuana rescheduling is underway, but DOT drug testing remains in place. Here’s what employers should know about medical marijuana, MRO review and FMCSA rules.

Oct 5 (Reuters) - US health officials are advancing the first government-funded clinical trials of the psychedelic drug ibogaine to treat opioid addiction and post-traumatic stress disorder, the FDA ...

The FDA has issued a final rule that would remove references to animal studies in its drug safety regulations, as part of a ...

By Yasmeen Abutaleb, Simon Lewis, Ammu Kannampilly and Emma Farge WASHINGTON/NAIROBI, Oct 6 (Reuters) - When US doctor ...

Carlos Alcaraz is making a strong statement at the US Open after returning from an over four-month-long absence due to a right wrist injury. The Spaniard beat Tommy Paul in straight sets to reach the ...

The agency plans to fast-track applications for several psychedelics, but it must also create a set of rules about who can take and administer them and in what settings.

Tyson Fury has now enrolled in the Voluntary Anti-Doping Association's testing programme ahead of his blockbuster showdown ...

DEA Chief Administrative Law Judge Derek Julius on Tuesday stayed pending proceedings on marijuana rescheduling after a ...

A new federal watchdog report is calling on agencies to improve their policies that govern the drug scheduling process—including how they evaluate substances and develop recommendations. The new U.S.

Revolution Medicines trades at 18x–58x projected 2027 U.S. revenue scenarios, leading to a Hold rating despite robust ...

Detailed results are competitive with Dupixent and Ebglyss, but the drug lacks differentiation amid an increasingly competitive landscape, one analyst argued.